Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4

Mariño, ZoePascasio Acevedo, Juan ManuelSánchez-Antolín, GloriaBaliellas, CarmePrieto Castillo, MartínMoreno, J.M.Carrión, José A.Fernández, I.Gómez, A.Montero, J.L.Castro-Iglesias, ÁngelesPascual, SoniaCabezas, JoaquínArencibia, Ana C.Calleja-Panero, José LuisSánchez Ruano, Juan JoséCastells, LluisAlbillos, A.Romero-Gómez, ManuelGarcía-Samaniego, J.Narváez, IsidroSerrano, T.Giráldez, ÁlvaroXiol, X.Hontagas, V.Cuervas-Mons Martínez, ValentínCrespo, J.Forns, Xavier2019-02-122019-02-122016Mariño Z, Pascasio JM, Sánchez-Antolín G, et al. Safety and efficacy of sofosbuvir plus simeprevir in a spanish cohort of 622 cirrhotic patients infected with genotypes 1 or 4. En: The International Liver Congress abstract book; 2016 Apr 13-17; Barcelons, Spain. Amsterdam: Elsevier; 2017. p. S831 (J Heaptol. 2016; 64 Suppl 2)0168-8278http://hdl.handle.net/2183/21714Presentation PosterengAtribución-NoComercial-SinDerivadas 3.0 Españahttp://creativecommons.org/licenses/by-nc-nd/3.0/es/Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4conference outputopen access